Newsclip®: [Health] Novartis sticks to $200 million FY Entresto f'cast after recommendation

"ZURICH: Novartis on Monday stuck to its full-year forecast of $200 million in revenue from its new heart failure medicine Entresto `as of right now`, even as analysts raised their estimates following an endorsement in global medical guidelines. `We're confident in the forecast we've laid out in the first-quarter call,` Chief Medical Officer Vas Narasimhan said in an interview. `As of right now, there's no changes to the outlook but we are also extremely confident in the long-term out",

0 comments | 1 clip



Last clipped by

Hey! Thanks for checking out Newsclip®!

Click on this Trending Newsclip® Stack to read other top media reports on this topic.

Be sure to clip to your personal newspaper, like, comment and share!

Newsclip® is the leader of Social News Discovery®.

Welcome to the Newsclip® beta release!

Please enjoy the site during our beta phase and provide us with feedback on suggestions and issue details. Please remember that we are still in beta and there will be issues and site changes during this time.

Newsclip® the leading Online Social Newspaper, find trending articles through Social News Discovery®!

Invite Friends to Newsclip®

Invite your Facebook friends to follow you!

You can reopen the "Getting Started Tutorial" dialog from within the About menu in the top right corner.